92.19MMarket Cap-630P/E (TTM)
1.460High1.370Low35.57KVolume1.410Open1.430Pre Close49.53KTurnover0.07%Turnover RatioLossP/E (Static)66.79MShares4.65052wk High0.88P/B67.38MFloat Cap1.10052wk Low--Dividend TTM48.82MShs Float55.720Historical High--Div YieldTTM6.29%Amplitude0.860Historical Low1.392Avg Price1Lot Size
Generation Bio Stock Forum
NEWS
Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting
Positive
Generation Bio's presentation at the ASGCT highlights significant advancements in iqDNA technology and ctLNP delivery systems, showcasing the company's commitment to innovation in genetic medicine.
The rapid enzymatic synthesis process utilized by Generation Bio enhances the performance of iqDNA, providing a potential breakthrough in ...
NEWS
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
Generation Bio Co. will present six abstracts at the ASGCT 27th Annual Meeting.
The abstracts will highlight preclinical data from the company's ctLNP and iqDNA platforms.
One of the presentations will focus on highly specific, in vivo delivery to T-cells with cell-targeted lipid nanoparticles.
The c...
No comment yet